Vericel (VCEL) Revenue (2011 - 2026)

Vericel has disclosed Revenue across 16 years of filings, most recently posting $68.4 million for Q1 2026.

• Revenue for Q1 2026 came in at $68.4 million, up 30.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $292.1 million (up 22.45% YoY), and the FY2025 annual result was $276.3 million, up 16.45% from the prior year.
• Revenue came in at $68.4 million for Q1 2026 at Vericel, down from $92.9 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $92.9 million in Q4 2025 to a low of $35.9 million in Q1 2022.
• The 5-year median for Revenue is $52.7 million (2024), against an average of $55.5 million.
• Across the five-year window, Revenue declined 6.26% in 2022 and jumped 30.09% in 2026, its largest moves.
• Vericel's Revenue stood at $52.7 million in 2022, then increased by 23.35% to $65.0 million in 2023, then advanced by 15.97% to $75.4 million in 2024, then grew by 23.27% to $92.9 million in 2025, then retreated by 26.36% to $68.4 million in 2026.
• The last three Revenue figures came in at $68.4 million (Q1 2026), $92.9 million (Q4 2025), and $67.5 million (Q3 2025), per Business Quant data.